Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 37Unknown 21Terminated 14Recruiting 14Withdrawn 6Active not recruiting 3

Sponsor Class

OTHER 3NIH 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Squamous Non Small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Afatinib × Clear all
NCT04497584 2025-10-01

Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC

University of Texas Southwestern Medical Center

Phase 2 Active not recruiting
12 enrolled
Thoracic

Advanced Squamous Non Small Cell Lung Cancer

NCT05215548 2025-02-19

Primary Tumor Resection With EGFR TKI for Stage IV NSCLC

National Taiwan University Hospital

Phase 2 Active not recruiting
100 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT01553942 2024-11-20

Afatinib With CT and RT for EGFR-Mutant NSCLC

Massachusetts General Hospital

Phase 2 Active not recruiting
19 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡